Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2021 annual report, the company carries out wholesale trade in medical goods and nutritional supplements, exports primarily to CIS countries.
| Line item | 2019 | 2020 | 2021 | CAGR |
|---|---|---|---|---|
| Total Revenue | 13,676 | 7,930 | 14,439 | +2.7% |
| Total COGS | 5,222 | 5,592 | 13,727 | +62.1% |
| Gross Profit | 8,454 | 2,338 | 712 | -71.0% |
| Gross Margin | 61.8% | 29.5% | 4.9% | |
| 148 | 295 | 504 | +84.7% | |
| EBITDA | 8,307 | 2,043 | 207 | -84.2% |
| EBITDA Margin | 60.7% | 25.8% | 1.4% | |
| Total D&A | 2 | 3 | 1 | -37.3% |
| EBIT / Operating Income | 8,304 | 2,040 | 206 | -84.2% |
| Total Other Income | 187 | 823 | 3,609 | +339.0% |
| Profit Before Tax | 8,117 | 1,217 | 3,403 | nmf |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 8,117 | 1,217 | 3,403 | nmf |
| Net Margin | 59.4% | 15.3% | 23.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.